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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYRed blood cells (RBCs), responsible for oxygen delivery and carbon dioxide exchange, are essential for our well-being. Alternative RBC
sources are needed to meet the increased demand for RBC transfusions projected to occur as our population ages. We previously have
discovered that erythroblasts derived from the early mouse embryo can self-renew extensively ex vivo for many months. To better
understand the mechanisms regulating extensive erythroid self-renewal, global gene expression data sets from self-renewing and differ-
entiating erythroblasts were analyzed and revealed the differential expression of Bmi-1. Bmi-1 overexpression conferred extensive self-
renewal capacity upon adult bone-marrow-derived self-renewing erythroblasts, which normally have limited proliferative potential.
Importantly, Bmi-1 transduction did not interfere with the ability of extensively self-renewing erythroblasts (ESREs) to terminallymature
either in vitro or in vivo. Bmi-1-induced ESREs can serve to generate in vitro models of erythroid-intrinsic disorders and ultimately may
serve as a source of cultured RBCs for transfusion therapy.INTRODUCTION
Every year in the United States, 14 million units of red
blood cells (RBCs) are used to treat more than 3.5 million
severely anemic patients (Ansari and Szallasi, 2012). This
great clinical need for RBCs is expected to increase as
our population ages. The current reliance on blood donors
is associated with infectious risks, high costs of screening,
and supply bottlenecks for rare blood types and for al-
loimmunized patients requiring chronic transfusions.
The in vitro production of RBCs is one potential solution
to meet this growing need for blood (Migliaccio et al.,
2012).
Adult humans synthesize more than two million RBCs
every second to maintain steady-state circulating levels.
These RBCs are derived from lineage-committed progeni-
tors that give rise to maturing erythroblasts that ulti-
mately enucleate. Erythropoiesis is regulated by several
cytokines, particularly erythropoietin (EPO) and stem
cell factor (SCF), which provide survival and proliferation
signals to erythroid progenitors (Koury and Bondurant,
1990; Chui and Russell, 1974). Additionally, glucocorti-
coid signaling facilitates the rapid expansion of the eryth-
ron that occurs in response to acute anemia (Bauer et al.,
1999).
Studies of viral-induced avian erythroleukemia led to the
discovery that signaling pathways downstream of EPO,
SCF, and glucocorticoids synergize to drive the in vitro
self-renewal of mammalian erythroid cells (Beug et al.,
1979; Panzenbo¨ck et al., 1998). Self-renewing erythro-Stemblasts (SREs) derived from postnatal sources undergo
limited ex vivo proliferation when cultured with EPO,
SCF, and the synthetic glucocorticoid dexamethasone
(DEX) (von Lindern et al., 1999; England et al., 2011).
We previously reported that erythroblasts derived from
the yolk sac and early fetal liver of the mouse embryo or
from differentiating mouse embryonic stem cells undergo
an initial phase of limited self-renewal, which is followed
by a subset of cells that undergo an extensive phase of
self-renewal (England et al., 2011). Even after 1060-fold
expansion in vitro, extensively self-renewing erythroblasts
(ESREs) maintain the capacity to terminally mature into
reticulocytes. While the continuous presence of EPO,
SCF, and DEX is necessary both for the restricted and for
the extensive phases of erythroblast proliferation, the
regulation of SRE and ESRE self-renewal remains poorly
understood.
To better understand the mechanisms underlying the
self-renewal of erythroid lineage cells, we generated
and compared global gene expression data sets from
SREs and ESREs as well as primary proerythroblasts
(ProEs). This analysis revealed that Bmi-1 and other
polycomb repressive complex 1 (PRC1) components
are upregulated in self-renewing erythroblasts. Impor-
tantly, overexpression of Bmi-1 conferred extensive
self-renewal capacity upon erythroblasts derived from
adult bone marrow without interfering with the ability
of these Bmi-1-induced ESREs (iESREs) to terminally
differentiate into enucleated RBCs both in vitro and
in vivo. iESREs may ultimately provide an alternativeCell Reports j Vol. 4 j 995–1003 j June 9, 2015 j ª2015 The Authors 995
Figure 1. Bmi-1 Is Highly Expressed in ESREs and Is Required for Erythroblast Self-Renewal
(A) SREs and ESREs were isolated from restricted and extensive phases of self-renewal, respectively. One representative growth curve of
four independent ESRE cultures is shown with timing of SRE and ESRE isolation boxed.
(B) Analysis of Affymetrix data sets revealed upregulation of genes associated with the PRC1 in ESREs and SREs compared to primary ProEs.
Several known targets of Bmi-1 are significantly downregulated in ESREs/SREs compared to ProEs (mean ± SEM; N = 4 independent
replicates for ESREs/SREs; N = 5 independent replicates for ProEs). p value was calculated using one-tailed Student’s t test. *p < 0.05;
**p < 0.01.
(C) Bmi-1 transcripts are expressed at significantly higher levels in ESREs compared to primary CFU-Es, ProEs, and maturing erythroblasts
(EryBs) (mean ± SEM; N = 3 independent replicates). p value was calculated using one-tailed Student’s t test. *p < 0.05.
(legend continued on next page)
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source of cultured RBCs to meet the growing need for
blood transfusions.RESULTS
Bmi-1 Expression Is Upregulated in ESREs and Is
Required for Erythroblast Self-Renewal
We previously determined that ESREs and primary ProEs
share similar morphological and immunophenotypic
characteristics, including high surface expression of KIT
(CD117) and transferrin receptor (CD71) (England et al.,
2011). Like ProEs, ESREs lie only 3–4 cell divisions up-
stream of reticulocytes; however, ESREs are blocked from
maturing in vitro by DEX (England et al., 2011). To better
understand the mechanisms regulating erythroid self-
renewal, we compared global gene expression of self-re-
newing erythroblasts in the restricted and extensive phases
of self-renewal (Figure 1A) with primary ProEs derived from
adult bone marrow.
Analysis of differentially expressed genes (Figure S1A) re-
vealed that several PRC1 components, including Bmi-1,
Ring1, and Phc1, were expressed at significantly higher
levels in self-renewing erythroblasts (Figure 1B). BMI-1
functions primarily as a repressor of multiple downstream
target genes, including Hoxa9 (Abdouh et al., 2009; Za-
charek et al., 2011; Biehs et al., 2013). Consistent with the
differential expression of Bmi-1, the potential downstream
targetHoxa9was not expressed in ESREs/SREs butwas high-
ly expressed in primary ProEs (Figures 1B and S1C). BMI-1
also represses several cell-cycle inhibitors, includingCdkn1b
(p27) and Cdkn2c (p18) (Leung et al., 2004; Abdouh et al.,
2009; Zhang et al., 2010), which were also reduced in
ESREs/SREs compared to ProEs (Figures 1B and S1C). The
differential expression of Bmi-1 was validated in ESREs
compared with primary late-stage erythroid progenitors
(CFU-Es), ProEs, and maturing erythroblasts isolated from
mouse bone marrow (Figures 1C and S1B).
We used a loss-of-function approach to test the hypoth-
esis that Bmi-1 regulates erythroid self-renewal. ESREs
transduced with shRNA targeting Bmi-1 rapidly died
following puromycin selection, while ESREs transduced
with a scrambled control vector continued to proliferate
(Figure 1D). Furthermore, the BMI-1 inhibitor PTC-209
reduced ESRE proliferation in a dose-dependent manner
(Figure 1E). Taken together, these data support the concept
that Bmi-1 is required for in vitro erythroblast self-renewal.See also Figure S1.
(D) shRNA-mediated knockdown of Bmi-1 rapidly decreased ESRE pro
three independent experiments).
(E) PTC-209, a BMI-1 inhibitor, caused a dose-dependent inhibition of
representative culture of six independent experiments is shown.
StemBmi-1 Is Sufficient to Induce Extensive Ex Vivo Self-
Renewal of Adult Erythroblasts Cultured with EPO,
SCF, and DEX
We next used a gain-of-function approach to determine
whether Bmi-1 can extend the proliferative capacity of
adult marrow-derived SREs, which normally proliferate
for only 1–2 weeks ex vivo (England et al., 2011). Empty
lentiviral vector-transduced adult SREs ceased proliferating
within 2 weeks, consistent with their limited ex vivo self-
renewal capacity. In contrast, erythroblasts from 10 of 11
bone-marrow-derived SRE cultures transduced with Bmi-1
proliferated at least 25 days (Figure 2A), while 3 cultures
of Bmi-1-induced ESREs (iESREs) were maintained for
more than 100 days (Figure 2B). iESREs were also generated
from adult mice with hereditary hemolytic anemia due to
Protein 4.1R deficiency (Figures S2A–S2D), providing a
proof of principle that this experimental approach can be
used to generate large numbers of mutant erythroblasts
that can facilitate the study of red cell-intrinsic disorders.
Since the Bmi-1 expression vector contains GFP, we
analyzed the percentage of Bmi-1-transduced erythroblasts
over time in culture.While 20%–30% of erythroblasts were
initially GFP+ following transduction, almost all of the
erythroblasts in the extensive phase of proliferation were
GFP+ (Figure 2C), consistent with the notion that Bmi-1
expression facilitates erythroblast self-renewal. Indeed,
BMI-1 is overexpressed in these transduced iESREs com-
pared to ESREs derived from fetal sources (Figure 2D).
SREs transduced with Bmi-1 display a high nuclear to
cytoplasmic ratio and a basophilic cytoplasm, similar to
the morphology of primary ProEs and to ESREs derived
from embryonic sources (Figure 2E). Like their embryo-
derived counterparts, iESREs expressed KIT and transferrin
receptor (Figure 2F). Similar to embryo-derived ESREs,
which remain highly dependent on EPO, SCF, and DEX
(England et al., 2011), Bmi-1-induced adult iESREs are
also dependent on the presence of each of these cytokines
to maintain ex vivo self-renewal (Figure 2G).iESREs Maintain the Potential to Terminally Mature
into Reticulocytes In Vitro
A mandatory feature of self-renewal is the generation of
daughter cells with the same identity as the parent cell,
which for ESREs include the maintenance of their capacity
to terminally differentiate into reticulocytes. Transfer of
iESREs and ESREs intomaturationmedia resulted in similarliferation after puromycin selection (one representative culture of
ESRE proliferation compared to vehicle (DMSO) control culture. One
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Figure 2. Bmi-1 Is Sufficient to Induce the Extensive Ex Vivo Self-Renewal of Adult Erythroblasts
(A) Lentiviral transduction of mouse Bmi-1 led to prolonged proliferation of bone-marrow-derived SREs grown in erythroid expansion
media. Erythroid cells transduced with an empty vector proliferated for 2 weeks, while erythroid cells transduced with a Bmi-1 over-
expression vector stably proliferated for more than a month (representative date from one of ten independent experiments). The dotted
line represents expected cell proliferation if cells divide daily.
(B) Bmi-1-induced ESRE (iESRE) was maintained for 100 days, exhibiting more than 1030-fold total erythroblast expansion.
(legend continued on next page)
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Figure 3. iESREs Terminally Mature into
Reticulocytes In Vitro
(A) Almost all of the Bmi-1-induced ESREs
(iESREs) in expansion cultures lack detect-
able hemoglobin (black line). Transfer of
iESREs and ESREs into maturation media on
day 0 resulted in rapid accumulation of
hemoglobin (red and blue lines, respec-
tively), quantified by benzidine staining.
(Mean ± SEM; N = 6 independent replicates
for iESRE self-renewing cultures; N = 7 and 3
independent replicates for iESRE and ESRE
maturation cultures, respectively.)
(B) Morphology of self-renewing (upper
panel) and maturing (lower panels) iESREs
stained with Wright-Giemsa. iESREs differ-
entiated in vitro into reticulocytes and
pyrenocytes (arrow). One representative
image of more than three independent ex-
periments is shown.
(C) In vitro maturation of iESREs is charac-
terized by the progressive downregulation
of KIT (CD117) and transferrin receptor
(CD71). Representative data from one of
three independent experiments are shown.kinetics of differentiation into reticulocytes as evidenced
by the rapid accumulation of hemoglobin (Figure 3A) and
by their transition at day 3 into enucleated reticulocytes
(Figure 3B; England et al., 2011). Consistent with normal
erythroblast maturation, iESREs also progressively downre-
gulated the cell surface expression of KITand transferrin re-
ceptor (Figure 3C). Taken together, these data indicate that
iESREs are immature erythroid precursors poised to termi-
nally mature in vitro.(C) The percentage of erythroblasts transduced with Bmi-1 (GFP+ cells
data from one of two independent experiments are shown.
(D) BMI-1 protein expression is increased in erythroblasts transduced w
data from one of three for ESREs and one of four for iESREs independ
(E) Bmi-1-induced iESREs exhibited a high nuclear to cytoplasmic rat
(F) iESREs express both KIT (CD117) and transferrin receptor (CD71)
pendent experiments are shown.
(G) iESREs remain dependent on the continued presence of EPO, SCF,
resulted in the rapid loss of cell proliferation. One representative cul
See also Figure S2.
StemiESREs Are Capable of Terminal Erythroid Maturation
In Vivo
We next asked whether iESREs also have the capacity to
mature in vivo. To track erythrocytes after transfusion,
iESREs were generated from the marrow of adult ubiquitin
C (UBC)-GFPmice that express GFP driven by the ubiquitin
C promoter. 5–103 107 iESREs were injected intravenously
intoNOD scid gamma (NSG) or C57BL/6Jmice treatedwith
1.5 Gy total body irradiation (TBI) to transiently suppress) when analyzed 3 days and 18 days after infection. Representative
ith FUGW-Bmi1. Actin served as an internal control. Representative
ent experiments are shown.
io and basophilic cytoplasm resembling proerythroblasts.
on their cell surface. Representative data from one of three inde-
and DEX for ex vivo self-renewal. Withdrawal of individual factors
ture of five independent experiments is shown.
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endogenous erythropoiesis. While most ESREs were local-
ized to the spleen and bone marrow 1 day after transfusion
(Figure S3B), a small percentage of GFP+ reticulocytes were
detected in the circulation, likely derived from the small
number of spontaneously maturing (benzidine+) cells
present in the self-renewing cultures (Figure 3A). A large,
transient wave of reticulocytes entered the bloodstream
between 4 and 8 days after iESRE transfusion into irradiated
mice (Figures 4A and S3C). At day 6, 40%–90% of the retic-
ulocytes in the bloodstream were GFP+ (Figures 4A and
S3C).
This robust wave of GFP+ reticulocytes was followed by
the circulation of GFP+ mature RBCs. iESRE-derived RBCs
persistently constituted 10%–15% of the circulating red
cell mass for 5 weeks (Figure 4A). iESRE-derived (GFP+) re-
ticulocytes and RBCs displayed a similar biconcave shape
when compared to their endogenous (GFP) counterparts
(Figure 4B). iESRE-derived reticulocytes were similar in
size to endogenous reticulocytes, while iESRE-derived
mature RBCs were significantly larger than endogenous
RBCs, consistent with their recent maturation as a neocyte
cohort on day 6 posttransfusion (Figure 4C). The circula-
tion of this large cohort of GFP+ RBCs for several weeks
suggests that they can deform normally to survive the
microcirculation. Indeed, pipette aspirationmeasurements
revealed that iESRE-derived RBCs had normal surface area
to volume ratios (sphericity) (Figures 4D and 4E). Further-
more, RBCs-derived from iESREs had similar hemoglobin
levels compared with endogenous RBCs (Figure S3D).
Taken together, these data indicate that iESREs mature syn-
chronously into reticulocytes both in vitro and in vivo and
can become fully mature RBCs in vivo with a functional
cytoskeleton that facilitates their persistent circulation for
weeks in the bloodstream.DISCUSSION
The self-renewal capacity of erythroid progenitors is an
important component of current protocols to generate
cultured RBCs for potential therapeutic purposes. However,
a major obstacle in generating the 2.5 3 1012 RBCs that
constitutes a single unit of blood is the limited capacity
of erythroblasts derived from neonatal and adult sources
to self-renew in vitro. Understanding the mechanisms
promoting extensive erythroid self-renewal could lead to
improved generation of cultured RBCs. Here, we have
discovered that Bmi-1 is preferentially expressed in self-re-
newing compared to differentiating erythroblasts. Impor-
tantly, we determined that overexpression of Bmi-1 is suffi-
cient to induce the extensive ex vivo self-renewal of adult
erythroblasts that normally are only capable of limited
self-renewal. These iESREs have a similar morphology, cell1000 Stem Cell Reports j Vol. 4 j 995–1003 j June 9, 2015 j ª2015 The Authsurface phenotype, and cytokine dependence compared
to ESREs derived from embryonic sources.
Bmi-1 regulates the self-renewal of several adult stem cell
populations, including hematopoietic, neural, and cancer
stem cells, often through repression of p16Ink4a/p19Arf
(Jacobs et al., 1999; Park et al., 2003; Molofsky et al.,
2003; Kreso et al., 2014). While we did not detect Cdkn2a
in erythroblasts (Kingsley et al., 2013), we did identify
several other potential BMI-1 target genes that are differen-
tially expressed in ESREs/iESREs, studies suggesting that
BMI-1 may function independently of p16Ink4a/p19Arf
repression in ESREs (Bruggeman et al., 2007; Abdouh
et al., 2009). The function of Bmi-1 in ESRE self-renewal
may be independent of its role in erythroid maturation,
where it was recently shown to positively regulate ribo-
somal protein genes (Gao et al., 2015).
Bmi-1 transduction of self-renewing erythroblasts did
not interfere with terminal in vitro maturation of iESREs
into reticulocytes. The generation of iESREs from adult Pro-
tein 4.1R null mice indicates that this experimental
approach can be used to generate large numbers of mutant
erythroblasts for the study of red-cell-intrinsic disorders,
particularly diseases that affect terminal stages of erythroid
maturation such as disorders of the membrane cytoskel-
eton or of globin gene expression.
Intravenous transfusion of iESREs resulted in the emer-
gence of a large wave of reticulocytes 4–8 days later. The
timing and the transient nature of this reticulocyte emer-
gence indicate that iESREs rapidly switched in vivo from a
self-renewal to a maturation program. This transient wave
of iESRE-derived reticulocytes generated a population of
mature RBCs that constituted 10%–15% of the total circu-
lating RBC mass from week 2 to week 6 following iESRE
transfusion. Consistent with a near normal life span,
iESRE-derivedRBCsdisplayednormal shapeanddeformabil-
ity when compared to co-circulating endogenous RBCs.
Transfusion of 103 107 iESREs resulted in the stable circula-
tion of approximately 1.63 109 RBCs, suggesting that each
iESRE generated 16–32 RBCs, consistent with the differenti-
ationpotential of normal ProE/CFU-E. Taken together, these
findings indicate that Bmi-1-induced ESREs are not immor-
talized but rather constitute committed erythroid precursors
that rapidly mature, not only in vitro but also in vivo.
These findings also distinguish iESREs from immortalized
erythroid cell lines generated by genetic perturbation of
multiple transcription regulators, including C-MYC, TP53,
E6/E7, and SOX2, someofwhichmustbeexogenously extin-
guished before terminal maturation can proceed (Huang
et al., 2014; Hirose et al., 2013; Kurita et al., 2013).
Our data indicate that Bmi-1 promotes the extensive
erythroid self-renewal of adult erythroblasts cultured
ex vivo with EPO, SCF, and DEX. iESREs may ultimately
provide an alternative source of cultured RBCs to meetors
Figure 4. Intravenous Transfusion of iESREs Results in a Transient Wave of Reticulocytes and the Circulation of iESRE-Derived RBCs
for Several Weeks
(A) Kinetics of GFP+/CD71+ reticulocytes (left panel) and GFP+/CD71 mature RBCs derived from 10 3 107 GFP+ iESREs transfused on day
0 into recipient mice. The percentages of iESRE-derived reticulocytes and RBCs were calculated as the number of GFP+ cells divided by the
total cell number in the parent gate (mean ± SEM; N = 3 mice).
(B) The morphology of circulating mature RBCs (Ter119+/CD71/DRAQ5), was visualized by imaging flow cytometry on day 6 post-GFP+-
iESRE transfusion. Reticulocytes and RBCs derived from iESREs (GFP+, upper panel) showed similar biconcave shape as endogenous (GFP,
lower panel) RBCs. Representative data from one of three mice are shown (size bar represents 10 mm).
(C) The size of iESRE-derived (GFP+) and endogenous (GFP) circulating reticulocytes and RBCs on day 6 post-transfusion were compared
by imaging flow cytometry. Reticulocytes were similar in size (mean ± SEM; N = 3 independent experiments; p = 0.22; left panel), while
iESRE-derived RBCs were significantly larger than endogenous RBCs (mean ± SEM; N = 3 independent experiments; right panel). p value was
calculated using two-tailed Student’s t test. *p < 0.05.
(D) Fluorescence-imaged microdeformation analysis of iESRE-derived (GFP+, upper panel) and endogenous (GFP, lower panel) RBCs.
(E) Sphericity of iESRE-derived (GFP+) and endogenous (GFP) RBCs on day 26 post-transfusion, based on micropipette measurements of
surface area and volume measurements (individual value ± SD; p value = 0.177). p value was calculated using two-tailed Student’s t test.
Representative data from one of three mice are shown.
See also Figure S3.
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the challenge of generating the extremely large numbers of
RBCs needed for transfusion therapy. Interestingly, iESREs
transfused in vivo result in large numbers of fully mature
RBCs, obviating the need to generate and fully mature
RBCs in vitro. Importantly, no GFP+ cells in peripheral
blood or tumors were detected in recipients 6 months after
transfusion (data not shown). However, host conditioning
and safety concernsmust be evaluated before iESREs can be
considered as a potential transfusion product.EXPERIMENTAL PROCEDURES
Mice and Tissues
All experiments were approved by the University of Rochester’s
Committee on Animal Resources. Mouse strains included outbred
ICR mice (Taconic Farms), C57BL/6J mice (Jackson Laboratory),
C57BL/6-Tg(UBC-GFP)30Scha/J (Jackson Laboratory), and Protein
4.1R knockoutmice (kindly provided byDr. JohnConboy). Tissues
from adult male bone marrow were processed as previously
described to derive iESREs (England et al., 2011). iESREs were trans-
fused into NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice (NSG; Jackson
Laboratory) or C57BL/6J mice.Erythroid Cell Evaluation
Cultured cells were stained with Wright-Giemsa or benzidine as
previously described (Palis et al., 1995). Images were acquired
and processed as previously published (England et al., 2011) using
Photoshop CS5 (Adobe). The immunophenotype of self-renewing
and maturing erythroid cells was analyzed with CD117 (phycoer-
ythrin [PE]-indocyanine [Cy] 7), CD71 (PE), and Ter119 (allophy-
cocyanin [APC] antibodies) using an LSR-II (BD Bioscience)
flow cytometer and FlowJo software (version 8.8.7). Additional
details about antibodies are in Supplemental Experimental
Procedures.Imaging Flow Cytometry Analysis
Circulating reticulocytes and RBCs were visualized with live
DAPI, Ter119hi(PE-Cy7), CD71+/(PE), DRAQ5, and GFP+/ us-
ing an imaging flow cytometer (ImageStream GenX; Amnis) and
analyzed with IDEAS software (version 4.0; Amnis). The size of
each population was measured after gating with live, single, and
focused cells using the ‘‘height’’ feature.Affymetrix Gene Expression Analysis
Erythroblasts from restricted and extensive phases of self-renewal
were isolated from two independent cultures initiated each from
E9.5 yolk sacs and E12.5 livers using FACS for Propidium Iodide
(PI), CD117hi(PE-Cy5), and CD71hi(PE). Primary ProEs from adult
bone marrow were isolated by FACS as described (Kingsley et al.,
2013). Gene expression data sets were generated using Affymetrix
Mouse Genome 430_2.0 GeneChips and analyzed as described
(Kingsley et al., 2013), including the identification of genes differ-
entially expressed between ESREs and primary ProEs. Microarray
data are available in the ArrayExpress database (http://www.ebi.
ac.uk/arrayexpress) under accession number E-MTAB-3112.1002 Stem Cell Reports j Vol. 4 j 995–1003 j June 9, 2015 j ª2015 The AuthTransfusion of Self-Renewing Erythroblasts
5–103 107 iESREs, generated fromUBC-GFPmice, were transfused
intravenously into each of three NSGmice and two C57BL/6Jmice
irradiated with 1.5 Gy TBI 6 hr previously, as well as an unirradi-
ated C57BL/6J mouse. RBCs were gated as single live (DAPI),
Ter119+(APC), CD71(PE) cells, and reticulocytes were gated as
Ter119+(APC), CD71+(PE) cells. Cells derived from transfused
iESREs were identified as GFP+ within each gate (Figure S3A).
RBCs collected from iESRE-transfused NSG recipient mice were
analyzed for surface area and volume (sphericity) as described
(Waugh et al., 2013).
Statistical Analysis
Statistical significance was calculated by Student’s t test. All data
are presented with mean ± SEM, except sphericity and relative he-
moglobin levels of RBCs, which are shown as value ± SD.
ACCESSION NUMBERS
Microarray data are available in the ArrayExpress database (http://
www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-
3112.
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